Schroder Investment Management Group lifted its stake in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 46.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,405,056 shares of the company’s stock after purchasing an additional 447,292 shares during the period. Schroder Investment Management Group owned 3.08% of Azenta worth $70,183,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of AZTA. Conestoga Capital Advisors LLC boosted its stake in shares of Azenta by 65.0% in the 4th quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company’s stock valued at $78,894,000 after purchasing an additional 621,830 shares during the last quarter. Norges Bank acquired a new stake in Azenta during the 4th quarter worth $25,403,000. Segall Bryant & Hamill LLC bought a new stake in shares of Azenta during the 4th quarter valued at $14,405,000. Principal Financial Group Inc. lifted its stake in shares of Azenta by 94.4% in the 4th quarter. Principal Financial Group Inc. now owns 221,083 shares of the company’s stock valued at $11,054,000 after purchasing an additional 107,339 shares during the period. Finally, First Eagle Investment Management LLC bought a new position in shares of Azenta in the 4th quarter worth $4,875,000. Institutional investors own 99.08% of the company’s stock.
Analysts Set New Price Targets
Several research firms have weighed in on AZTA. Needham & Company LLC increased their target price on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research note on Thursday, February 6th. Stephens reiterated an “overweight” rating and issued a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd. TD Cowen raised shares of Azenta to a “hold” rating in a research note on Thursday, February 27th. Finally, Evercore ISI upped their target price on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research note on Thursday, February 6th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $58.75.
Azenta Price Performance
NASDAQ AZTA opened at $34.64 on Tuesday. Azenta, Inc. has a one year low of $33.33 and a one year high of $63.58. The firm has a market cap of $1.58 billion, a P/E ratio of -11.62 and a beta of 1.52. The stock’s 50-day moving average is $44.75 and its 200-day moving average is $46.18.
Azenta (NASDAQ:AZTA – Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Equities analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
- Five stocks we like better than Azenta
- What is MarketRankā¢? How to Use it
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Stock Splits, Do They Really Impact Investors?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Growth Stocks: What They Are, What They Are Not
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.